After-Hours Movers 8/4: SCLN, PLNR, DVAX, HYC, PODD, WFMI Higher; BBND, XRM, GUID, FBN, DIVX, APEI Lower
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) 33% HIGHER; reports Q2 EPS of $0.16, versus the analyst estimate of $0.02 and compared to a loss of $0.01 in the same quarter last year. Revenue for the quarter was $22 million, versus the consensus of $16.75 million. Sees FY09 sales of $69-$71 million, versus the consensus of $65.87 million. Sees FY09 EPS of $0.10-$0.14, versus the consensus of $0.06.
Planar Systems (Nasdaq: PLNR) 32% HIGHER; reports Q3 loss of $0.04, 15 cents better than the analyst estimate of ($0.19). Revenue for the quarter was $44.1 million, versus the consensus of $36.65 million.
Dynavax Technologies Corporation (Nasdaq: DVAX) 20.8% HIGHER; is moving higher after-hours after the company announced it has met with the U.S. FDA to discuss its plans to resume development of HEPLISAVTM, the Company's Phase 3 investigational hepatitis B vaccine. Click here to see the full report.
BigBand Networks (Nasdaq: BBND) 18.7% LOWER; reports Q2 EPS of $0.09, 6 cents better than the analyst estimate of $0.03. Revenue for the quarter was $39.0 million, versus the consensus of $41.45 million. For the third quarter of 2009, management provides the following outlook: Non-GAAP net loss per share is expected to be in the range of $0.13 to $0.15 vs. consensus for $0.06 profit. Net revenues are expected to be approximately $20 million vs. consensus of $45.82 million.
Hypercom Corporation (NYSE: HYC) 16.7% HIGHER; reports Q2 EPS of $0.02, versus the analyst estimate of ($0.09) and compared to a loss of $0.21 in the same quarter last year. Revenue for the quarter was $106.8 million, versus the consensus of $98.84 million.
Xerium Technologies, Inc. (NYSE: XRM) 15.2% LOWER; reports Q2 EPS of $0.03, versus the analyst estimate of ($0.04). Revenue for the quarter was $120.8 million, versus the consensus of $129.16 million.
Insulet Corporation (Nasdaq: PODD) 15% HIGHER; reports Q2 loss of $0.73, 5 cents below the analyst estimate of ($0.68). Revenue for the quarter was $14.6 million, versus the consensus of $13.91 million. Sees Q3 revs $16.5M to $17.5M versus consensus of $15.3M. Sees FY09 revs $58M to $65M versus $58.6M consensus.
Guidance Software, Inc. (Nasdaq: GUID) 13.5% LOWER; reports Q2 loss of $0.18, ex-items, versus the analyst estimate of ($0.04). Revenue for the quarter was $16.4 million, versus the consensus of $20.33 million. Sees FY09 loss of $0.57-$0.42, versus the consensus looking for a loss of $0.08, and revs of $72-$77 million, versus the Street estimate of $87.4 million.
Whole Foods Market (Nasdaq: WFMI) 13.2% HIGHER; reports Q3 EPS of $0.25, including a LIFO credit of 2cents, 5 cents better than the analyst estimate of $0.20. Revenue for the quarter was $1.9 billion, versus the consensus of $1.86 billion.
Furniture Brands (NYSE: FBN) 12.9% LOWER; reports Q2 loss of $0.33, versus the analyst estimate of ($0.05). Revenue for the quarter was $288.3 million, versus the consensus of $341.93 million.
TNS Inc. (NYSE: TNS) 10% HIGHER; reports Q2 EPS of $0.56, 12 cents better than the analyst estimate of $0.44. Revenue for the quarter was $122 million, versus the consensus of $114.89 million. Raises FY09 EPS guidance from $1.69-$1.84 to $2.04-$2.15, versus the consensus of $1.78, and revs from $468-$482 to $478-$486 million, compared to the Street estimate of $475 million.
BRE Properties, Inc. (NYSE: BRE) 9% HIGHER; reports Q2 FFO of $0.70, 9 cents better than the analyst estimate of $0.61. Revenue for the quarter was $86.3 million, versus the consensus of $80.83 million. The company has adjusted its FFO guidance for the full year 2009 to a range of $2.42 to $2.52 per share, from the previous range of $2.38 to $2.53. The revised guidance range includes the nonroutine income of $2.0 million, or $0.04 per share, from the gain on retirement of debt recorded in the second quarter. Excluding the nonroutine income item and APB-14-1 noncash interest, per share core FFO amounts for 2009 are expected to range $2.50 to $2.60. (Consensus is $2.44)
Dollar Thrifty Automotive Group (NYSE: DTG) 8.8% HIGHER; reports Q2 EPS of $0.30 versus the analyst estimate of ($0.23). Revenue for the quarter was $399.6 million, versus the consensus of $416 million. Sees rental revenue down 8% to 10% for 2009.
DivX (Nasdaq: DIVX) 8% LOWER; reports Q2 loss of $0.00, 4 cents better than the analyst estimate of ($0.04). Revenue for the quarter was $15.2 million, versus the consensus of $14.52 million.
Conseco, Inc. (NYSE: CNO) 7.8% HIGHER; reports Q2 EPS of $0.22, ex-items, in-line with the analyst estimate of $0.22. Revenue for the quarter was $1.1 billion, versus the consensus of $1.11 billion.
Hill International, Inc. (NYSE: HIL) 7% HIGHER; reports Q2 EPS of $0.12, 2 cents better than the analyst estimate of $0.10. Revenue for the quarter was $104.3 million, versus the consensus of $98.31 million. Boosts buyback plan to $40 million.
American Public Education (Nasdaq: APEI) 6.4% LOWER; reports Q2 EPS of $0.28, 1 cent better than the analyst estimate of $0.27. Revenue for the quarter was $35.7 million, versus the consensus of $35.08 million. Sees Q3 EPS of $0.25-$0.27, versus the consensus of $0.31 and revs of $35-$36 million, versus the consensus of $38.1 million.
Albany Molecular Research (Nasdaq: AMRI) 6.2% LOWER; reports Q2 EPS of $0.04, 5 cents worse than the analyst estimate of $0.09. Revenue for the quarter was $51.3 million, versus the consensus of $51.90 million. “In the third quarter, we expect contract revenue to range from $37 million to $41 million, a decrease of 24% to 32% from the third quarter of 2008. (Consensus is $51.01M) For the full year 2009, we expect contract revenue to range from $154 million to $162 million, a decrease of 17% to 21% versus 2008.” (Consensus is $211.71M) Click here for the full report.
Big 5 Sporting Goods Corporation (Nasdaq: BGFV) 6.1% HIGHER; reports Q2 EPS of $0.22, 7 cents better than the analyst estimate of $0.15. Revenue for the quarter was $216.0 million, versus the consensus of $215.90 million. For the fiscal 2009 third quarter, the Company expects same store sales in the flat to positive low-single digit range and earnings per diluted share in the range of $0.27 to $0.34. (Consensus is $0.23)
Cambrex (NYSE: CBM) 6.1% LOWER; reports Q2 EPS of $0.19, 9 cents better than the analyst estimate of $0.10. Revenue for the quarter was $59.8 million, versus the consensus of $58.90 million.
Kindred Healthcare (NYSE: KND) 5.6% HIGHER; reports Q2 EPS of $0.45, 11 cents better than estimates. Revenues were $1.1 billion vs. $1.08 billion consensus. The Company maintained its 2009 earnings guidance for continuing operations. The Company expects consolidated revenues for 2009 to approximate $4.3 billion. Income from continuing operations for 2009 is expected to approximate $54 million to $57 million or $1.35 to $1.45 per diluted share. (Consensus is $4.31B and $1.32, respectively) The Company also provided its earnings outlook for the third quarter of 2009, estimating diluted earnings per share between breakeven to $0.05 per diluted share vs. $0.03 consensus.
Tessera Technologies Inc (Nasdaq: TSRA) 5.3% HIGHER; reports Q2 EPS of $0.37, ex-items, versus the analyst estimate of $0.14. Revenue for the quarter was $62.3 million, versus the consensus of $59.93 million. Sees Q3 revs of $60-$62 million, versus the consensus of $56.8 million.
Molina Healthcare (NYSE: MOH) 5.3% LOWER; reports Q2 EPS of $0.56, 3 cents lower than the analyst estimate of $0.59. Revenue for the quarter was $926 million, versus the consensus of $878.74 million. Revises FY09 EPS guidance of $2.15, versus the consensus of $2.23.
Petrohawk Energy Corporation (NYSE: HK) 5.3% LOWER; today announced that it has filed a preliminary prospectus supplement to its existing shelf registration statement with the U.S. SEC relating to an underwritten public offering of 25,000,000 shares of its common stock. The underwriters will also have a 30-day option to purchase up to 3,750,000 additional shares of common stock from Petrohawk. The company also reported Q2 EPS of $0.10, ex-items, 5 cents better than the analyst estimate of $0.05. Revenue for the quarter was $227.3 million, versus the consensus of $258.23 million.
HealthSouth Corporation (NYSE: HLS) 4.7% HIGHER; reports Q2 EPS of $0.39 (ex-items), 15 cents better than estimates. Revenues were $483.7 million vs. $471.78 million consensus. As a result of its strong operating results for the first six months of 2009, the Company is increasing its previously provided guidance for 2009. Adjusted Consolidated EBITDA guidance for 2009 has been increased from a range of $342 million to $352 million to a range of $354 million to $362 million. Adjusted diluted earnings per share have been increased from a range of $0.85 to $0.90 per share to a range of $1.15 to $1.25 per share. (FY EPS Consensus is $1.05)
Cogent (Nasdaq: COGT) 4.6% HIGHER; reports Q2 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter was $31.8 million, versus the consensus of $32.44 million.
Ctrip.com International, Ltd. (Nasdaq: CTRP) 4.3% HIGHER; reports Q2 EPS of $0.39 vs. $0.29 consensus. Revenues were $70 million vs. $64.96 million consensus. For the third quarter of 2009, Ctrip expects the year-on-year net revenue growth of approximately 25%. This forecast reflects Ctrip's current and preliminary view, which is subject to change.
American Medical Systems (Nasdaq: AMMD) 4.3% LOWER; reports Q2 EPS of $0.29, 5 cents better than the analyst estimate of $0.24. Revenue for the quarter was $126.4 million, versus the consensus of $127.88 million. The Company narrowed the range of its full year 2009 revenue guidance to $495 to $510 million from previous guidance in the range of $495 to $515 million. (Consensus is $507.76M) Third quarter revenue is estimated in the range of $113 million to $119 million. (Consensus is $118.96M)
Bio-Rad Laboratories, Inc. (NYSE: BIO) 4% HIGHER; reports Q2 EPS of $1.37, 31 cents better than the analyst estimate of $1.06. Revenue for the quarter was $427.2 million, versus the consensus of $423.18 million.
Unum Group (NYSE: UNM) 3% HIGHER; reports Q2 EPS of $0.65, 4 cents better than the analyst estimate of $0.61. Raise FY09 EPS guidance from $2.45-$2.55 to $2.50-$2.60, versus the consensus of $2.48.
Kraft Foods (NYSE: KFT) 1.2% LOWER; reports Q2 EPS of $0.56, 2 cents better than the analyst estimate of $0.54. Revenue for the quarter was $10.2 billion, versus the consensus of $10.37 billion. Boosts guidance, sees FY09 EPS $1.93 from $1.88 consensus is 1.93.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
Related Categories
Special ReportsStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
